RA
ENDP

Royce & Associates’s Endo International plc ENDP Stock Holding History

Royce & Associates’s Portfolio ENDP Stock Details ENDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-1,300
Closed -$91K – 1439
2014
Q2 		$91K Buy
+1,300
New +$86.9K ﹤0.01% 1345

Other funds holding ENDP

JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BRC
Blue Ridge Capital New York $215M AUM
GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Royce & Associates's ENDP Position: Q3 2014 in Review

Royce & Associates sold out of Endo International plc (ENDP) in Q3 2014, closing a stake of 1,300 shares — an estimated $91K sold.

Royce & Associates first reported a position in ENDP in Q2 2014 and held it in 1 quarter. The position peaked at $91K in Q2 2014. 286 funds tracked by Wall St. Rank hold ENDP as of Q3 2014.

  • Royce & Associates reported no remaining Endo International plc position as of Q3 2014 after selling out during the quarter.
  • Royce & Associates sold 1,300 Endo International plc shares in Q3 2014, an estimated $91K.
  • Royce & Associates first reported a position in Endo International plc in Q2 2014 and held it in 1 quarter.
  • Royce & Associates's Endo International plc position peaked at $91K in Q2 2014.
  • 286 funds tracked by Wall St. Rank held Endo International plc as of Q3 2014.

Based on Royce & Associates's 13F filing for Q3 2014, filed 12 Nov 2014.